X
Despite trial miss, Novartis still believes in Entresto for HFpEF
https://pharmaphorum.com/news/despite-trial-miss-novartis-still-believes-in-entresto-for-hfpef/
Entresto
The biggest pharma stories of 2016 so far
The top 10 pharma milestones of the year to date.
Novartis ramping up investment in new drugs
Swiss pharma loses patent on key cancer drug
10 drugs – and their prices – which changed pharma in 2015
In a record-breaking year for pharma, which drugs were the most outstanding?